NCT07103512Recruiting
Scalene Hold Relax Technique With Conventional Physical Therapy in Asthma
Additional Effects of Scalene Hold Relax Technique With Conventional Physical Therapy On Pulmonary Function in Asthma Patient
Source: ClinicalTrials.gov · Last updated 22 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To determine the additional effects of scalene hold relax technique with conventional exercises on pulmonary function in asthma patients
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- First submitted
- 29 Jul 2025
- Start date
- 21 Aug 2025
- Primary completion date
- Oct 2025
- Lead sponsor
- Riphah International University
- Diseases
- Asthma
- NCT number
- NCT07103512
What you commit to
- Study type: Interventional
- Planned participants: 26
- From 21 Aug 2025 to the primary completion date, Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient with any comorbid condition such as cardiovascular disease diabetes or other chronic illness
- Patient with any psychological condition that may interfere with participation or adherence to the study protocol
Other
- Patient who do not provide consent
Who the study is looking for
- Patient diagnosed with Allergic asthma
- Both male and female will be included
- Age between 20 to 44 years.
Age in the registry: 22 years to 44 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| DHQ Hospital Coordinator of this site? Confirm its status | Mānsehra | Pakistan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.